Miyake, N., Chikumi, H., Yamaguchi, K., Takata, M., Takata, M., Okada, K., . . . Yamasaki, A. (2019). Effect of Cetuximab and EGFR Small Interfering RNA Combination Treatment in NSCLC Cell Lines with Wild Type EGFR and Use of KRAS as a Possible Biomarker for Treatment Responsiveness. Yonago Acta Med.

Miyake, Naomi, Hiroki Chikumi, Kosuke Yamaguchi, Miyako Takata, Miki Takata, Kensaku Okada, Tsuyoshi Kitaura, Masaki Nakamoto, i Akira Yamasaki. "Effect of Cetuximab and EGFR Small Interfering RNA Combination Treatment in NSCLC Cell Lines With Wild Type EGFR and Use of KRAS As a Possible Biomarker for Treatment Responsiveness." Yonago Acta Med 2019.

Miyake, Naomi, et al. "Effect of Cetuximab and EGFR Small Interfering RNA Combination Treatment in NSCLC Cell Lines With Wild Type EGFR and Use of KRAS As a Possible Biomarker for Treatment Responsiveness." Yonago Acta Med 2019.